Intermittent preventive treatment with sulphadoxine-pyrimethamine is effective in preventing maternal and placental malaria in Ibadan, south-western Nigeria.
about
The impact of IPTi and IPTc interventions on malaria clinical burden - in silico perspectivesConsequences of gestational malaria on birth weight: finding the best timeframe for intermittent preventive treatment administrationKnowledge and utilization of intermittent preventive treatment for malaria among pregnant women attending antenatal clinics in primary health care centers in rural southwest, Nigeria: a cross-sectional study.Burden of malaria during pregnancy at the time of IPTp/SP implementation in Gabon.Diagnosing congenital malaria in a high-transmission setting: clinical relevance and usefulness of P. falciparum HRP2-based testing.Utilisation of malaria preventive measures during pregnancy and birth outcomes in Ibadan, NigeriaMaternal malaria, birth size and blood pressure in Nigerian newborns: insights into the developmental origins of hypertension from the Ibadan growth cohort.Patterns of case management and chemoprevention for malaria-in-pregnancy by public and private sector health providers in Enugu state, Nigeria.Coverage and efficacy of intermittent preventive treatment with sulphadoxine pyrimethamine against malaria in pregnancy in Côte d'Ivoire five years after its implementation.Congenital malaria in Calabar, Nigeria: the molecular perspective.Malaria in pregnancy: the difficulties in measuring birthweightIntermittent preventive treatment with sulfadoxine-pyrimethamine against malaria and anemia in pregnant womenPatterns and predictors of self-medication amongst antenatal clients in Ibadan, Nigeria.Relatively low prevalence of peripheral and placental Plasmodium infection at delivery in bangui, central african republicUse and effects of malaria control measures in pregnancy in Lagos, NigeriaThe role of prophylactic antimalarial in the reduction of placental parasitemia among pregnant women in Calabar, NigeriaLow coverage of intermittent preventive treatment for malaria in pregnancy in Nigeria: demand-side influences.Determinants of timely uptake of ITN and SP (IPT) and pregnancy time protected against malaria in Bukoba, TanzaniaTemporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya.Effectiveness of Intermittent Preventive Treatment in Pregnancy with Sulphadoxine-Pyrimethamine against Submicroscopic falciparum Malaria in Central Region, Ghana.Determinants of intermittent preventive treatment of malaria during pregnancy (IPTp) utilization in a rural town in Western Nigeria.Sub-optimal delivery of intermittent preventive treatment for malaria in pregnancy in Nigeria: influence of provider factors.Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancyPrevalence of intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) use during pregnancy and other associated factors in Sekondi-Takoradi, GhanaMalaria risk factors in women on intermittent preventive treatment at delivery and their effects on pregnancy outcome in Sanaga-Maritime, Cameroon.[Factors associated with the failure of Intermittent Preventive Treatment for malaria among pregnant women in Yaounde].Effect of intermittent preventive treatment of malaria on the outcome of pregnancy among women attending antenatal clinic of a new Nigerian teaching hospital, Ado-Ekiti.Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431VPlacental malaria among HIV-infected and uninfected women receiving anti-folates in a high transmission area of Uganda.Prevalence of Dihydrofolate reductase gene mutations in Plasmodium falciparum isolate from pregnant women in Nigeria.Scaling up of intermittent preventive treatment of malaria in pregnancy using sulphadoxine-pyrimethamine: prospects and challenges.How many low birthweight babies in low- and middle-income countries are preterm?A note on "Malaria at parturition in Nigeria: current status and delivery outcome".Prevalence, risk factors and effects of placental malaria in the UMTH, Maiduguri, North-eastern, Nigeria: a cross-sectional study.High prevalence of dihydrofolate reductase gene mutations in Plasmodium falciparum parasites among pregnant women in Nigeria after reported use of sulfadoxine-pyrimethamine.Efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine on placental parasitemia in pregnant women in midwestern Nigeria.The protective effectiveness of control interventions for malaria prevention: a systematic review of the literature.Prevalence of Low Birth Weight before and after Policy Change to IPTp-SP in Two Selected Hospitals in Southern Nigeria: Eleven-Year Retrospective Analyses.Sickle Cell Disease Clinical Trials and Phenotypes
P2860
Q27344985-458F1667-3A7E-42E8-B546-ECD8315EE939Q28730587-57B4D08F-D075-4DE3-8EB0-0C57C7F57EF2Q33480328-B13F5A05-365B-4169-ADBE-D4B7AAE383B1Q33617540-52F8B317-EF6D-4FA2-9848-8CA6295BC105Q33704972-EBB44812-957F-40E6-9041-643B3F307972Q33996106-9BB564CC-8755-48CF-8126-610649063A22Q34023644-79B51379-E1AE-4541-BDAE-4CCDC66D7524Q34253496-20508F69-B3D6-4B4A-B71F-ECAF4A54FDF5Q34579161-B8E746C6-93A3-42DF-94D0-E421C1943413Q34592157-6243D8F9-DF9E-44EB-BAC6-A4DE082C2CF8Q35054459-8E8B52C4-1576-4B73-8296-4D5F7F8E7469Q35065561-91455313-3174-4F2B-95B3-0DBA1191FC71Q35542943-78CEE408-CC65-45FD-ABB5-432EE8B82058Q35660355-9213D9D3-12BB-4CF8-A08B-F214A639E843Q35757558-DFE523BA-0D7B-4654-8114-65AEB5CED76CQ35896245-CE05D796-8CCC-434C-AAA7-E406FA3385CEQ36000539-F84DD7AB-C014-4B85-B05B-EFE434136F16Q36058137-FC51F096-EA53-4D6A-91E8-8763E8CE7066Q36077922-047DC8F8-1491-499A-B351-FA54C6010571Q36095646-73E99A1F-1497-465B-843D-271C2967C72AQ36263956-3BAEF4B6-BC90-4B1B-A386-A99832180152Q36309107-5CDB2E95-CAB4-414C-83DB-E1034B3D5E17Q36327851-FCF2D275-2650-4FFF-A2AC-751AB0AE939AQ36612513-C1AF8419-E070-4D92-ACF0-45A3EFBF1024Q36908893-818CF113-AC52-42F2-99A2-F3C378B4E7CBQ36973292-F9381F3A-5B1A-4C69-9334-EC416B0C2ED6Q37034963-566A8996-E8E3-4E82-BBC6-A2C5BD11C38EQ37391118-3120F961-F389-43FD-941F-CB21EF4ADA7BQ37429678-87ED3E7B-909D-42DD-833A-B27ACC779486Q37481867-FB3D8632-9372-40AD-833E-F17E21B905D2Q37738205-EF813B2F-010E-49EC-9069-C19C76841367Q37866662-B4D25072-9434-4341-AC09-D875258A3F0DQ42916674-C689CDD0-9350-4AD5-87CE-1325570709EEQ44270197-A5D00772-075D-4101-AD68-8BF84958C066Q47566100-1CDBE6E4-771C-4E1D-BDCC-0289BAABB7FEQ47957003-641F0F0B-6208-497F-9BA2-58143E19FC54Q48019728-BE0C9D75-2A68-4650-A05C-BC848760BB08Q55256193-52B03C3D-45DC-49A8-8A8A-6019E52E2C98Q58581652-0FE6ACEA-67A0-425E-8040-AE0EE2840587
P2860
Intermittent preventive treatment with sulphadoxine-pyrimethamine is effective in preventing maternal and placental malaria in Ibadan, south-western Nigeria.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Intermittent preventive treatm ...... Ibadan, south-western Nigeria.
@ast
Intermittent preventive treatm ...... Ibadan, south-western Nigeria.
@en
type
label
Intermittent preventive treatm ...... Ibadan, south-western Nigeria.
@ast
Intermittent preventive treatm ...... Ibadan, south-western Nigeria.
@en
prefLabel
Intermittent preventive treatm ...... Ibadan, south-western Nigeria.
@ast
Intermittent preventive treatm ...... Ibadan, south-western Nigeria.
@en
P2093
P2860
P921
P356
P1433
P1476
Intermittent preventive treatm ...... Ibadan, south-western Nigeria.
@en
P2093
Bidemi O Yusuf
Francis F Fadero
Lateef A Salako
Olugbenga A Mokuolu
P2860
P2888
P356
10.1186/1475-2875-6-88
P577
2007-07-06T00:00:00Z
P5875
P6179
1039389876